Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma

ChemMedChem

Volumn 6, Issue 12, 2011, Pages 2287-2293

  Zanellato, Ilaria ^a   Bonarrigo, Ilaria ^a   Sardi, Manuele ^a   Alessio, Manuela ^a   Gabano, Elisabetta ^a   Ravera, Mauro ^a   Osella, Domenico ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Antitumor agents; Cancer; Ethacrynic acid; Glutathione S transferase; Malignant mesothelioma; Platinum

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DIAMMINOBIS(ETHACRYNATO)PLATINUM; DIAMMINODICHLORIDOBIS(ETHACRYNATO)PLATINUM; ETACRYNIC ACID; GLUTATHIONE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; HUMAN; HUMAN CELL; IC 50; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; COORDINATION COMPLEXES; DRUG EVALUATION, PRECLINICAL; ETHACRYNIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MESOTHELIOMA; PLATINUM;

EID: 82955161519     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100426     Document Type: Article

References (38)

1. A. A. Mujoomdar, T. R. Tilleman, W. G. Richards, R. Bueno, D. J. Sugarbaker, J. Thorac. Cardiovasc. Surg. 2010, 140, 352-355.
2. K. Järvinen, P. Pietarinen-Runtti, K. Linnainmaa, K. O. Raivio, C. M. Krejsa, T. Kavanagh, V. L. Kinnula, Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 278, 696-702.
3. K. Kinnula, K. Linnainmaa, K. O. Raivio, V. L. Kinnula, Br. J. Cancer 1998, 77, 1097-1102.
4. M. Ray, H. L. Kindler, Chest 2009, 136, 888-896.
5. J. Reedijk, Chem. Rev. 1999, 99, 2499-2510.
6. M. A. Fuertes, C. Alonso, J. M. Pérez, Chem. Rev. 2003, 103, 645-662.
7. J. Reedijk, J. M. Teuben in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Ed.: B. Lippert), Wiley-VCH, Weinheim, 1999, pp.339-362.
8. M. G. Cherian, S. B. Howell, N. Imura, C. D. Klaassen, J. Koropatnick, J. S. Lazo, M. P. Waalkes, Toxicol. Appl. Pharmacol. 1994, 126, 1-5.
9. K. Järvinen, Y. Soini, K. Kahlos, V. L. Kinnula, Hum. Pathol. 2002, 33, 748-755.
10. S. Goto, T. Iida, S. Cho, M. Oka, S. Kohno, T. Kondo, Free Radical Res. 1999, 31, 549-558.
11. C. Peklak-Scott, P. K. Smitherman, A. J. Townsend, C. S. Morrow, Mol. Cancer Ther. 2008, 7, 3247-3255.
12. S. Chatterjee, I. Biondi, P. J. Dyson, A. Bhattacharyya, J. Biol. Inorg. Chem. 2011, 16, 715-724.
13. V. Adler, Z. Yin, S. Y. Fuchs, M. Benezra, L. Rosario, K. D. Tew, M. R. Pincus, M. Sardana, C. J. Henderson, C. R. Wolf, R. J. Davis, Z. Ronai, EMBO J. 1999, 18, 1321-1334.
14. K. Segers, S. Kumar-Singh, J. Weyler, J. Bogers, M. Ramael, J. VanMeerbeeck, E. VanMarck, J. Cancer Res. Clin. Oncol. 1996, 122, 619-624.
15. A. Dejmek, U. Brockstedt, A. Hjerpe, APMIS 1998, 106, 489-494.
16. P. Ruzza, A. Rosato, C. R. Rossi, M. Floreani, L. Quintieri, Anticancer Agents Med. Chem. 2009, 9, 763-777.
17. S.-S. Byun, S. W. Kim, H. Choi, C. Lee, E. Lee, BJU Int. 2005, 95, 1086-1090.
18. W. H. Ang, I. Khalaila, C. S. Allardyce, L. Juillerat-Jeanneret, P. J. Dyson, J. Am. Chem. Soc. 2005, 127, 1382-1383.
19. W. H. Ang, S. Pilet, R. Scopelliti, F. Bussy, L. Juillerat-Jeanneret, P. J. Dyson, J. Med. Chem. 2005, 48, 8060-8069.
20. S. Komune, J. B. Snow, Arch. Otolaryngol. 1981, 107, 594-597.
21. D. Ding, H. Jiang, P. Wang, R. Salvi, Hear. Res. 2007, 226, 129-139.
22. S. C. Dhara, Indian J. Chem. 1970, 8, 193-194.
23. F. D. Rochon, L. M. Gruia, Inorg. Chim. Acta 2000, 306, 193-204.
24. I. Zanellato, C. D. Boidi, G. Lingua, P.-G. Betta, S. Orecchia, E. Monti, D. Osella, Cancer Chemother. Pharmacol. 2011, 67, 265-273.
25. L. J. Parker, L. C. Italiano, C. J. Morton, N. C. Hancock, D. B. Ascher, J. B. Aitken, H. H. Harris, P. Campomanes, U. Rothlisberger, A. DeLuca, M. LoBello, W. H. Ang, P. J. Dyson, M. W. Parker, Chem. Eur. J. 2011, 17, 7806-7816.
26. S. Awasthi, S. K. Srivastava, F. Ahmad, H. Ahmad, G. A. Ansari, Biochim. Biophys. Acta 1993, 1164, 173-178.
27. S. Aizawa, K. Ookawa, T. Kudo, J. Asano, M. Hayakari, S. Tsuchida, Cancer Sci. 2003, 94, 886-893.
28. D. Sheehan, G. Meade, Biochem. Soc. Trans. 2000, 28, 27-32.
29. C. Neumann, Boubakari, R. Grünert, P. J Bednarski, Anal. Biochem. 2003, 320, 170-178.
30. N. Mantel, Ann. N.Y. Acad. Sci. 1958, 76, 909-931.
31. M. Oliver, N. Harrison, J. Bishop, P. Cole, G. Laurent, J. Cell Sci. 1989, 92, 513-518.
32. E. Magnani, E. Bettini, Brain Res. Brain Res. Protoc. 2000, 5, 266-272.
33. T. C. Chou, P. Talalay, Adv. Enzyme Regul. 1984, 22, 27-55.
34. R. J. Knox, F. Friedlos, D. A. Lydall, J. J. Roberts, Cancer Res. 1986, 46, 1972-1979.
35. M. J. Pabst, W. H. Habig, W. B. Jakoby, J. Biol. Chem. 1974, 249, 7140-7147.
36. J. A. Cook, H. I. Pass, A. Russo, S. Iype, J. B. Mitchell, Int. J. Radiat. Oncol. Biol. Phys. 1989, 16, 1321-1324.
37. J. C. Fernández-Checa, N. Kaplowitz, Anal. Biochem. 1990, 190, 212-219.
38. J. A. Cook, S. N. Iype, J. B. Mitchell, Cancer Res. 1991, 51, 1606-1612.